Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Specimen Handling 113Magnetic Resonance Spectroscopy 78Biopsy 78pembrolizumab 61Cyclophosphamide 52fludarabine 43Carboplatin 26Nivolumab 24Cetuximab 24Cisplatin 23venetoclax 22Radiotherapy 21Bevacizumab 21atezolizumab 18X-Rays 18fludarabine phosphate 17Radiation 17Ipilimumab 17Fluorouracil 17Gemcitabine 16Paclitaxel 15Leucovorin 15Cytarabine 15Temozolomide 14Pemetrexed 14Irinotecan 14durvalumab 13Oxaliplatin 13Azacitidine 13Prednisone 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Multiparametric Magnetic Resonance Imaging × 30 days × Clear all
NCT03388619 2026-05-27

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
30 enrolled 16 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡